Written by AGORA doctoral candidate Zafeiria Karlou
Contemporary societies are experiencing a profound demographic transformation characterized by declining fertility rates and rapidly increasing life expectancy (World Economic Outlook, 2025). This shift has produced what is commonly referred to as a demographic crisis: a growing aging population relative to the working-age population. According to global projections, the number of people aged 65 and older will exceed those under 18 in several developed economies within the next decade, a demographic configuration without historical precedent (United Nations, 2023). Population decline often coincides with an aging population, as the proportion of elderly people increases relative to younger age groups. Healthcare systems are under tremendous pressure to find scalable delivery methods (Gabaliņa et al., 2025). The central challenge is therefore how can societies use metaverse to establish health care solutions that can support longevity rather than survival.
Product innovation activities should incorporate metaverse technologies to keep up with these rapid demographic changes and deliver enhanced medical solutions. Metaverse can provide new capabilities for product innovation offering more accuracy and efficacy in the medical sector. For instance, product innovation efforts can significantly upgrade clinical capabilities through the integration of digital twins. In a deployed environment, digital twins can replicate the physical twin’s actual behavior and state. As a result, digital twins provide a real-time perspective on the state of tangible assets like machinery. For example, clinicians can perform countless simulations using digital twins of human hearts to inform individualized medical decision-making and disease management. Additionally, immersive 3D visualizations and image fusion are made possible by the metaverse in specialized fields like nuclear medicine (Tang et al., 2024). Compared to conventional 2D techniques, this enables physicians to detect subtle injuries with more accuracy. Telemedicine breaks down geographical barriers for practitioners through platforms like Virtual Tumor Boards (VTB) (Tang et al., 2024). This type of platforms facilitates working together on complicated medical cases when radiologists, pathologists, and oncologists from various locations can make better treatment decisions thanks to these shared spaces.
Furthermore, the metaverse can support a sizable leap in the innovation of products and services, enhancing the efficiency of healthcare provision in an immersive, realistic and more personalized medium. AI will further provide real-time diagnoses of illnesses with increased accuracy. For example, UC San Francisco-based Labyrinth VR is a spatial wayfinding game which helps elderly individuals to boost their long-term memory. Besides, the company Mindmaze enables evidence-based, protocolized therapies for the restoration of cognitive and cardiovascular function, as well as therapies and technologies that enable clinicians to maximize the delivery of cognitive neurorehabilitation.
All in all, the metaverse can act as a demographic equalizer allowing not only aging population but all people to remain healthy and productive with a reduced environmental footprint.